Alzheimer's disease and vascular dementia are the two most commone forms of dementia.
Approximately 65-90% of all dementia cases represent one of these two types. Early
differentiation of the two diseases is crucial to proper therapeutic treatment...
The estimated population in Connecticut is 3,510,297 and ranks 4th in life expectancy at an average age of 78.7 years. As the population ages, the incidence of Alzheimer's disease is expected to rise proportionately. In Connecticut, there are over...
Alzheimer's Disease (AD) is a type of dementia characterized by a gradual and
progressive decline of intellectual functioning, affecting 20-40% of the population
over the age of eighty. It results in cognitive deficits such as impairments in...
Animal models of Huntington's disease (HD) that utilize 3-nitropropionic acid (3-NPA) in the initiation of oxidative stress
and accelerated brain-aging have been extensively studied. When administered to rodents, 3-NPA irreversibly...
This research was designed to examine the efficacy of three cognitive training programs in two different populations. Study 1 examined the efficacy of (1) a group-based interactive training program (Mind Aerobics), (2) an individualized...
The Quick Cognitive Screening Test is a brief and portable, mid-range cognitive assessment tool used to detect specific cognitive deficits in individuals with traumatic brain injury, psychiatric disorders, and neurological disorders (Mate-Kole,...
